Shuttle Pharmaceuticals Bolsters Investor Relations with New Partnership
Company Announcements

Shuttle Pharmaceuticals Bolsters Investor Relations with New Partnership

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has released an update.

The Company has partnered with John Columbia Inc. to boost its investor relations and outreach efforts, complementing the ongoing support from its current associate, Lytham Partners, LLC. This strategic move aims to strengthen the Company’s engagement with the investor community.

For further insights into SHPH stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
GlobeNewswireShuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
TheFlyShuttle Pharmaceuticals announces publication of manuscript on SP-1-303
TipRanks Auto-Generated NewsdeskShuttle Pharmaceuticals Welcomes New CFO Timothy Lorber
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!